These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 4256949

  • 21. Fibrinolytic and renin activity in renal vein blood of patients with renovascular hypertension.
    Nowak A, Kokot F, Czekala Z, Dosiak J, Kuska J.
    Thromb Diath Haemorrh; 1969 Feb 28; 21(1):12-9. PubMed ID: 4237621
    [No Abstract] [Full Text] [Related]

  • 22. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM, Isacson S.
    J Clin Pathol; 1972 Jul 28; 25(7):638-9. PubMed ID: 5070268
    [No Abstract] [Full Text] [Related]

  • 23. Fibrinolytic activation of plasma by means of urokinase in vitro and in vivo.
    Nanninga LB, Guest MM.
    Thromb Diath Haemorrh; 1970 Oct 31; 24(1):33-42. PubMed ID: 5483972
    [No Abstract] [Full Text] [Related]

  • 24. Circulatory changes during and after surgical anesthesia in hypertensive patients treated with clonidine, methyldopa and reserpine.
    Ryhänen P, Hanhela R, Jouppila R, Vuopala U.
    Int Surg; 1984 Oct 31; 69(1):29-33. PubMed ID: 6735626
    [Abstract] [Full Text] [Related]

  • 25. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U, Nilsson IM, Isacson S.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976 Oct 31; 103(3):372-80. PubMed ID: 63424
    [No Abstract] [Full Text] [Related]

  • 26. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
    Stein D, Heins M, Schoebel FC, Pels K, Jax TW, Stiegler H, Reinauer H, Strauer BE, Leschke M.
    Thromb Haemost; 1997 May 31; 77(5):970-4. PubMed ID: 9184412
    [Abstract] [Full Text] [Related]

  • 27. Biochemical pharmacology of the fibrinolysin system of the rat. 3. The mechanism of phenformin (1-(beta-phenethyl)-biguanide)-induced fibrinolytic activity.
    Lassman HB, Back N.
    J Pharmacol Exp Ther; 1974 May 31; 189(2):333-43. PubMed ID: 4275233
    [No Abstract] [Full Text] [Related]

  • 28. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
    Andrassy K, Egbring R, Egli H.
    Thromb Diath Haemorrh; 1969 Nov 15; 22(2):377-90. PubMed ID: 4245334
    [No Abstract] [Full Text] [Related]

  • 29. The fibrinolytic system in patients with right ventricular failure treated with Novurit.
    Worowski K, Gabryelewicz A, Prokopowicz J, Poplawski A.
    Thromb Diath Haemorrh; 1970 Jun 30; 23(3):500-3. PubMed ID: 5432191
    [No Abstract] [Full Text] [Related]

  • 30. [Long-term treatment of hypertensive disease "in the vascular sclerosis phase" with furosemide and reserpine. Clinico-statistical and hematochemical considerations].
    Levi GF, Proto C.
    Minerva Cardioangiol; 1970 Mar 30; 18(3):188-93. PubMed ID: 5443865
    [No Abstract] [Full Text] [Related]

  • 31. Resting levels of blood fibrinolysis in hyperlipoproteinemia.
    Brakman P, Astrup T, Levy RI, Fredrickson DS.
    J Appl Physiol; 1974 Apr 30; 36(4):430-3. PubMed ID: 4274385
    [No Abstract] [Full Text] [Related]

  • 32. [Efficient modification of hypertension therapy].
    Sarre H, Poser G, Dietler P.
    Med Klin; 1968 Apr 05; 63(14):540-4. PubMed ID: 4972529
    [No Abstract] [Full Text] [Related]

  • 33. Antifibrin action of phenformin.
    Banerjee RN, Kumar V, Rao SR, Sahni AL, Arya M, Bardhan J.
    Diabetologia; 1975 Apr 05; 11(2):105-11. PubMed ID: 1149944
    [Abstract] [Full Text] [Related]

  • 34. [Effect of a combination of dihydroergocristine methanesulfonate, clopamide and reserpine on blood pressure and renal hemodynamics in renal and essential hypertension].
    Ludwig H, Thielecke R, Weichert G.
    Arzneimittelforschung; 1970 Aug 05; 20(8):1079-83. PubMed ID: 5536507
    [No Abstract] [Full Text] [Related]

  • 35. Altered endogenous fibrinolysis and biochemical factors in atherosclerosis.
    Peabody RA, Tsapogas MJ, Wu KT, Deveraj KT, Karmody AM, Eckert C.
    Arch Surg; 1974 Aug 05; 109(2):309-13. PubMed ID: 4276947
    [No Abstract] [Full Text] [Related]

  • 36. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 05; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 37. [Fibrinolytic system in patients with acute hypertension without renal failure].
    Lasierra Cirujeda J, Ramos González I.
    Rev Clin Esp; 1980 Jan 31; 156(2):93-7. PubMed ID: 7367705
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA, Parashchak AP, Ryzhova VL.
    Klin Med (Mosk); 1983 Aug 31; 61(8):24-8. PubMed ID: 6358666
    [No Abstract] [Full Text] [Related]

  • 39. [Ambulatory therapy of hypertension with briserin mite].
    Schütz E.
    Med Welt; 1970 May 30; 22():1040-3. PubMed ID: 5509755
    [No Abstract] [Full Text] [Related]

  • 40. [Changes in blood uric acid during prolonged treatment with diuretic-hypotensive drugs in aged patients].
    Scalabrino R, Grimaldi MG.
    G Gerontol; 1967 Mar 30; 15(3):349-60. PubMed ID: 5606923
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.